Synthetic Biology Market, by Product (Oligonucleotides, Enzymes, Synthetic Cells, and Others); by Technology (Gene Synthesis, Genome Engineering, DNA Sequencing, and Others); by End User (Biotechnology & Pharmaceutical Industry, Academics & Research Insti

Synthetic Biology Market, by Product (Oligonucleotides, Enzymes, Synthetic Cells, and Others); by Technology (Gene Synthesis, Genome Engineering, DNA Sequencing, and Others); by End User (Biotechnology & Pharmaceutical Industry, Academics & Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Synthetic biology is a process of design and construction of biologically based parts, devices, and entirely novel biological systems or the reengineering of existing biological systems. The goal of synthetic biology is to create design, and redesign biological systems and devices to understand biological processes. It helps to improve human welfare. Synthetic biology can be used to improve the diagnosis of diseases, and it can be used to make new treatments.
Market Dynamics
Opportunity exhibits by developing technologically advanced production platfoms. Moreover, increasing funding for synthetic biology is anticipated to drive the market growth. For instance, 65 synthetic biology companies raised US$ 1.9 billion in funding in the first half of 2019. Additionally, emerging application of synthetic biology in smart drug development, personalized medication, gene therapy, repair and tissue regeneration, cell reprogramming, and in vivo drug synthesis is likely to drive the growth of the global synthetic biology market. Synthetic biology is one of the leading research field that brings the new opportunities. This is contribute to drive the growth of market in near future
Key features of the study:
This report provides an in-depth analysis of the global synthetic biology market, market size (US$ Billion), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market
This study also provides key insights into market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global synthetic biology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies, Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies, Inc., Codexis, Inc., EnBiotix, Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics, LLC, and Genomatica, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global synthetic biology market report caters to various stakeholders in this industry, including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global synthetic biology market
Detailed Segmentation:
Global Synthetic Biology Market, By Product:
Oligonucleotides
Enzymes
Synthetic Cells
Others
Global Synthetic Biology Market, By Technology:
Gene Synthesis
Genome Engineering
DNA Sequencing
Others
Global Synthetic Biology Market, By End user:
Biotechnology & Pharmaceutical Industry
Academics & Research Institutes
Others
Global Synthetic Biology Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Thermo Fisher Scientific
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Synbio Technologies
Merck KGaA
Agilent Technologies, Inc.
GenScript
Amyris
Eurofins Genomics GmbH
Integrated DNA Technologies, Inc.
Codexis, Inc.
EnBiotix, Inc.
Synthego
New England Biolabs (UK) Ltd.
Scarab Genomics, LLC
Genomatica, Inc.
“*” marked represents similar segmentation in other categories in the respective section.